5-MeO-DALT

From Wikipedia, the free encyclopedia
Jump to: navigation, search
5-MeO-DALT
5-MeO-DALT.svg
Systematic (IUPAC) name
N-allyl-N-[2-(5-methoxy
-1H-indol-3-yl)ethyl]
prop-2-en-1-amine
Clinical data
Legal status
?
Identifiers
CAS number 928822-98-4 N
ATC code ?
PubChem CID 50878551
ChemSpider 21106245 YesY
Chemical data
Formula C17H22N2O 
Mol. mass 270.375 g/mol
 N (what is this?)  (verify)

5-MeO-DALT or N,N-diallyl-5-methoxytryptamine is a psychedelic tryptamine first synthesized by Alexander Shulgin.

Chemistry[edit]

The full name of the chemical is N-allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-en-1-amine. It is chemically related to the compounds 5-MeO-DPT and DALT.

History[edit]

The first material regarding the synthesis and effects of 5-MeO-DALT was sent from Alexander Shulgin to a researcher in May 2004, after which it was circulated online. In June 2004 5-MeO-DALT became available from internet research chemical vendors. In August 2004 the synthesis and effects of 5-MeO-DALT were published by Erowid.[1]

Dosage[edit]

Doses ranging from 12–20 mg were tested by Alexander Shulgin's research group.[2]

Dangers[edit]

There are numerous anecdotal reports of users consuming dosages far in excess of those tested by Alexander Shulgin,[citation needed] although there is no published literature on the toxicity of 5-MeO-DALT.

Drug prohibition laws[edit]

It is legal in the UK because the allyl group is not an alkyl group, which the law requires for a tryptamine to be illegal.

Japan[edit]

5-MeO-DALT became a controlled substance in Japan from April 2007, by amendment to the Pharmaceutical Affairs Law.[3]

Sweden[edit]

Sveriges riksdag added 5-MeO-DALT to schedule I ("substances, plant materials and fungi which normally do not have medical use") as narcotics in Sweden as of May 1, 2012, published by Medical Products Agency in their regulation LVFS 2012:6 listed as 5-MeO-DALT N-allyl-N-[2-(5-metoxi-1H-indol-3-yl)etyl]-prop-2-en-1-amin.[4]

Notes[edit]

  1. ^ [1], Morris, H. (11 May 2010). "The Last Interview With Alexander Shulgin". Vice Magazine. Retrieved 2011-02-24.
  2. ^ [2]
  3. ^ "厚生労働省:平成18年度無承認無許可医薬品等買上調査の結果について". Retrieved 2012-06-26.  (Japanese)
  4. ^ http://www.lakemedelsverket.se/upload/lvfs/LVFS_2012_6.pdf

External links[edit]